Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,882 | -2,087 | -1,610 | -1,077 | 512 |
| Depreciation Amortization | 48 | 47 | 34 | 16 | 77 |
| Other Working Capital | 853 | 475 | 22 | 375 | 1,934 |
| Other Operating Activity | -503 | -503 | 1 | 1 | -5,474 |
| Operating Cash Flow | $-2,485 | $-2,067 | $-1,554 | $-685 | $-2,951 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1 | 1 | N/A | N/A | N/A |
| Other Investing Activity | 300 | 114 | 89 | 0 | 35 |
| Investing Cash Flow | $301 | $115 | $89 | $0 | $35 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,240 | 1,940 | 1,440 | 600 | 3,310 |
| Debt Repayment | -1 | N/A | N/A | N/A | -603 |
| Other Financing Activity | -18 | 0 | 0 | 0 | -8 |
| Financing Cash Flow | $2,221 | $1,940 | $1,440 | $600 | $2,699 |
| Beginning Cash Position | 99 | 99 | 99 | 99 | 315 |
| End Cash Position | 136 | 86 | 74 | 14 | 99 |
| Net Cash Flow | $37 | $-12 | $-25 | $-85 | $-217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,485 | -2,067 | -1,554 | -685 | -2,951 |
| Capital Expenditure | -2 | -2 | N/A | N/A | N/A |
| Free Cash Flow | -2,487 | -2,070 | -1,554 | -685 | -2,951 |